Pfizer drug company decides to close plant in Australia, shift production to Croatia

The US pharmaceutical company Pfizer will close the Australian plant which produces the API for HSP-130, a candidate version of Amgen’s Neulasta, and shift production to Croatia, Pfizer told Hina.

"Met4Pharm" project example of science-economy synergy

Science Minister Predrag Sustar said this was an excellent example of cooperation between the scientific and business sectors.